FDA inspection
Shandong Anxin Pharmaceutical Co., Ltd.: FDA inspection ending Sep 27, 2013
FDA inspection 851840 · No Action Indicated (NAI) · Jinan
Key facts
| Inspection ID | 851840 |
|---|---|
| Firm | Shandong Anxin Pharmaceutical Co., Ltd. |
| FEI number | 3004229375 |
| Address | No. 849 Dongjiazhen, Licheng |
| City | Jinan |
| Country | China |
| Fiscal year | 2013 |
| Inspection end date | Sep 27, 2013 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data